|Articles|September 15, 2014

Kickstart Your Experience with the CPhI Pre-Connect Congress

An opportunity to broaden your horizon on the latest and hottest industry trends that shape the pharmaceutical landscape.

The CPhI Pre-Connect Congress, which starts a day before the show, is a great opportunity to broaden your horizon on the latest and hottest industry trends that shape the pharmaceutical landscape.

This event is attended by industry experts and senior executives from all the various segments of the pharmaceutical industry, from those involved in small molecules and biologics, as well as generic drugs and biosimilars, to excipients and advanced drug delivery technologies.

There will be a commercial track and a technical track, with eight modules to choose from—API sourcing in emerging markets; excipients & formulation; strategic alliance & partnering; drug delivery systems & technology; generics & supergenerics; biopharmaceuticals; biosimilars & biobetters; and new trends in oncology.

Presentations and discussions will focus on the supply chain security of starting materials in light of new regulations; market opportunities in Brazil, China, and India; the changing dynamics of outsourcing and key considerations for creating successful partnerships; how to achieve multifunctional performance of next generation excipients; approaches to overcome bioavailability challenges and achieve optimal delivery profile for better patient outcomes; and perspectives on the global generic drug market, amongst others.

The Pre-Connect Congress will take place at the same location as CPhI Worldwide, at Paris Nord Villepinte, France, on October 6. More information, including registration details, can be found here.


Related to this article

Regulatory Roundup—September 2026
The FDA opened an expedited IND pilot, tightened scrutiny of foreign trial data, and finalized a rule recognizing non-animal testing methods. In Europe, the EMA advanced pharmaceutical legislation reform, restricted 2 legacy products, and opened an injectable-iron safety review.